CME Group
$263.14Change from previous close: −0.74%Absolute change: −$1.96
At a glance
- Revenue growth
- +6.32%
- 2025 vs 2024
- Net income growth
- +15.50%
- 2025 vs 2024
- Net margin
- 62.6%
- 2024: 57.6%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6,507 | 6,120 | 5,579 | 5,019 | 4,690 | 4,884 | 4,868 | 4,309 | 3,645 | 3,595 |
| Cost of revenue | 907 | 850 | 829 | 753 | — | — | — | — | — | — |
| Gross profit | 6,507 | 6,120 | 5,579 | 5,019 | 4,690 | 4,884 | 4,868 | 4,309 | 3,645 | 3,595 |
| Selling, general and administrative | 1,751 | 1,646 | 1,515 | 1,399 | 1,418 | 1,491 | 1,447 | 1,126 | 929 | 971 |
| Operating income | 4,259 | 3,937 | 3,458 | 3,003 | 2,605 | 2,673 | 2,656 | 2,681 | 2,301 | 2,223 |
| EBIT | 4,259 | 3,937 | 3,458 | 3,003 | 2,605 | 2,673 | 2,656 | 2,681 | 2,301 | 2,223 |
| EBITDA | 4,590 | 4,274 | 3,811 | 3,365 | 2,990 | 3,138 | 3,129 | 2,930 | 2,510 | 2,448 |
| Interest expense | 173 | 161 | 159 | 163 | 167 | 166 | 178 | 158 | 117 | 124 |
| Pre-tax income | 5,331 | 4,541 | 4,154 | 3,490 | 3,374 | 2,722 | 2,690 | 2,778 | 2,526 | 2,288 |
| Income tax | 1,258 | 1,016 | 927 | 799 | 737 | 616 | 574 | 814 | -1,537 | 754 |
| Net income | 4,072 | 3,526 | 3,226 | 2,691 | 2,636 | 2,105 | 2,117 | 1,962 | 4,063 | 1,534 |
| Net income to common shareholders | 4,021 | 3,482 | 3,186 | 2,657 | 2,617 | 2,105 | 2,117 | 1,962 | 4,063 | 1,534 |
| Basic EPS | 11.18 | 9.69 | 8.87 | 7.41 | 7.30 | 5.88 | 5.93 | 5.73 | 12.00 | 4.55 |
| Diluted EPS | 11.16 | 9.67 | 8.86 | 7.40 | 7.29 | 5.87 | 5.91 | 5.71 | 11.94 | 4.53 |
| Average shares (basic) | 360 | 359 | 359 | 359 | 358 | 358 | 357 | 342 | 339 | 337 |
| Average shares (diluted) | 360 | 360 | 360 | 359 | 359 | 359 | 358 | 344 | 340 | 339 |
| Dividend per share | 5.00 | 4.60 | 4.40 | 4.00 | 3.60 | 3.40 | 3.00 | 2.80 | 2.64 | 2.40 |